These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8161607)
1. Conformational study of cyclo[Gln-Trp-Phe-Gly-Leu-Met] as NK-2 antagonist by NMR and molecular dynamics. Siahaan TJ; Lutz K J Pharm Biomed Anal; 1994 Jan; 12(1):65-71. PubMed ID: 8161607 [TBL] [Abstract][Full Text] [Related]
2. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study. Zhang M; Quinn TP; Wong TC Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730 [TBL] [Abstract][Full Text] [Related]
3. Solution conformation of c-[Gln-Trp-Phe-Gly-Leu-Met], a NK-2 tachykinin antagonist. Amodeo P; Rovero P; Saviano G; Temussi PA Int J Pept Protein Res; 1994 Dec; 44(6):556-61. PubMed ID: 7705977 [TBL] [Abstract][Full Text] [Related]
4. Cyclic peptides as selective tachykinin antagonists. Williams BJ; Curtis NR; McKnight AT; Maguire JJ; Young SC; Veber DF; Baker R J Med Chem; 1993 Jan; 36(1):2-10. PubMed ID: 7678430 [TBL] [Abstract][Full Text] [Related]
5. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors. Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462 [TBL] [Abstract][Full Text] [Related]
6. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor. Goso C; Astolfi M; Parlani M; Manzini S Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437 [TBL] [Abstract][Full Text] [Related]
7. Comparative conformational analysis and in vitro pharmacological evaluation of three cyclic hexapeptide NK-2 antagonists. Wollborn U; Brunne RM; Harting J; Hölzemann G; Leibfritz D Int J Pept Protein Res; 1993 Apr; 41(4):376-84. PubMed ID: 8388367 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity study of neurokinins: antagonists for the neurokinin-2 receptor. Dion S; Rouissi N; Nantel F; Jukic D; Rhaleb NE; Tousignant C; Télémaque S; Drapeau G; Regoli D; Naline E Pharmacology; 1990; 41(4):184-94. PubMed ID: 1964226 [TBL] [Abstract][Full Text] [Related]
9. Cyclic hexapeptide NK-2 antagonists. Hölzemann G; Löw A; Harting J; Greiner HE Int J Pept Protein Res; 1994 Aug; 44(2):105-11. PubMed ID: 7527014 [TBL] [Abstract][Full Text] [Related]
10. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor. Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Ferrer C; Giolitti A; Guelfi M; Rotondaro L; Warner FJ; Maggi CA J Pharmacol Exp Ther; 1999 Aug; 290(2):487-95. PubMed ID: 10411554 [TBL] [Abstract][Full Text] [Related]
11. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val). Liu ZP; Gierasch LM Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655 [TBL] [Abstract][Full Text] [Related]
12. Different mechanism of tachykinin NK2 receptor blockade by SR 48968 and MEN 10,627 in the guinea-pig isolated gallbladder and colon. Patacchini R; De Giorgio R; Giachetti A; Maggi CA Eur J Pharmacol; 1994 Dec; 271(1):111-9. PubMed ID: 7698194 [TBL] [Abstract][Full Text] [Related]
13. Conformation of a neurokinin antagonist in solution. 2D NMR and restrained molecular dynamics study. Malikayil JA; Harbeson SL Int J Pept Protein Res; 1992 Jun; 39(6):497-505. PubMed ID: 1328098 [TBL] [Abstract][Full Text] [Related]